A new research project, spearheaded by neuroscientist Ruslan Rust and student Gavin Spillard, is set to investigate the critical question of whether microplastics disrupt brain function and increase vulnerability to dementia, particularly in individuals carrying the APOE4 genetic risk factor. The project, partially funded through ResearchHub's innovative endowment model, aims to rapidly move from concept to data, addressing a gap in understanding the environmental contributors to neurological diseases.
Plastic particles have been detected in human brain tissue, often accumulating around blood vessels and appearing at higher concentrations in some individuals with dementia. However, the exact mechanisms by which these microplastics might affect the brain, including their potential to breach the blood-brain barrier (BBB) or their interaction with genetic predispositions like APOE4, remain largely unknown. Ruslan Rust, an Assistant Professor at the University of Southern California (USC) specializing in the blood-brain barrier and neurogenetics, highlighted this critical knowledge gap.
"We still don’t know if they disrupt the blood-brain barrier (BBB). We don’t know if carriers of APOE4 (a major genetic risk factor) are more vulnerable," Rust stated in a recent social media post. He further explained that his student, Gavin Spillard, decided to pursue this urgent question. Recognizing the typical year-long funding cycles for such research, Rust leveraged his work with ResearchHub to partially fund the project through his endowment, personally covering half of the microgrant.
ResearchHub, co-founded by Brian Armstrong, aims to accelerate scientific research through community-led funding mechanisms, including endowments that generate "Funding Credits" from ResearchCoin (RSC) holdings. This model allows for rapid allocation of funds to promising projects, bypassing traditional bureaucratic hurdles. The platform emphasizes open publishing and peer review, fostering transparency and collaboration within the scientific community.
The research plans to compare how APOE3 versus APOE4 human iPSC-pericytes handle microplastics, measuring uptake and transcriptional responses. Furthermore, the team will test these effects in BBB models and brain tissue, ultimately seeking to identify and pharmacologically reverse any APOE-specific signatures. This approach builds upon recent findings, including a 2025 study by Jaime Ross and colleagues, which demonstrated that short-term exposure to polystyrene microplastics altered cognition and immune markers in APOE4 mice in a sex-dependent manner, mirroring human Alzheimer's symptoms. The urgency of this new project underscores the growing concern over microplastic ubiquity and their potential impact on human health.
